Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology

Added 517 days ago (15.12.2020)
Authors: Dixon, L., Coughlan, C., Karunaratne, K., Gorgoraptis, N., Varley, J., Husselbee, J., Mallon, D., Carroll, R., Jones, B., Boynton, C., Pritchard, J., Youngstein, T., Mason, J., Gabriel, C.
Read article